featured
First-Line vs Second-Line Fulvestrant for Hormone Receptor-Positive Advanced Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Breast
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
First-Line vs Second-Line Fulvestrant for Hormone Receptor-Positive Advanced Breast Cancer: A Post-Hoc Analysis of the CONFIRM Study
Breast 2018 Apr 01;38(xx)144-149, A Di Leo, G Jerusalem, R Torres, D Verhoeven, K Pendergrass, L Malorni, J Lichfield, M MartinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.